IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks

Range Low Price High Price Comment
30 days $84.38 $96.99 Monday, 15th Apr 2024 BPMC stock ended at $85.18. This is 2.37% less than the trading day before Friday, 12th Apr 2024. During the day the stock fluctuated 4.09% from a day low at $84.38 to a day high of $87.84.
90 days $72.25 $100.98
52 weeks $43.89 $100.98

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
2023-06-28 $63.02 $65.21 $62.34 $65.09 460 060
2023-06-27 $63.11 $63.63 $62.33 $62.99 657 219
2023-06-26 $63.82 $63.85 $61.84 $62.72 626 420
2023-06-23 $63.50 $64.30 $63.03 $63.82 867 084
2023-06-22 $63.28 $65.20 $63.20 $64.08 769 203
2023-06-21 $63.75 $64.96 $62.15 $63.66 712 105
2023-06-20 $61.31 $64.48 $61.10 $64.00 617 223
2023-06-16 $62.25 $62.25 $60.34 $61.31 1 568 269
2023-06-15 $58.19 $61.00 $57.68 $60.89 582 593
2023-06-14 $58.49 $59.12 $57.26 $58.76 440 634
2023-06-13 $57.99 $59.42 $57.42 $58.30 394 835
2023-06-12 $58.57 $58.91 $57.20 $57.63 279 743
2023-06-09 $56.69 $59.15 $56.64 $58.47 411 762
2023-06-08 $59.49 $60.13 $56.44 $56.61 487 505
2023-06-07 $58.25 $60.98 $57.84 $60.03 1 663 751
2023-06-06 $56.25 $58.41 $55.64 $58.00 950 346
2023-06-05 $52.05 $56.16 $51.52 $56.02 1 480 800
2023-06-02 $57.02 $58.64 $56.34 $58.22 381 317
2023-06-01 $56.49 $57.45 $55.74 $56.79 364 314
2023-05-31 $56.66 $58.40 $54.95 $56.52 530 583
2023-05-30 $57.88 $58.19 $56.05 $56.41 482 369
2023-05-26 $57.32 $58.06 $54.02 $57.75 784 739
2023-05-25 $58.18 $58.18 $54.24 $54.28 529 635
2023-05-24 $58.28 $58.50 $56.76 $58.00 688 514
2023-05-23 $57.66 $59.89 $57.55 $58.50 1 303 608
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT